Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study

Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study

Abstract Background Whether chronic inflammation increases prostate cancer risk remains unclear. This study investigated whether chronic inflammatory diseases (CID) or anti-inflammatory medication use (AIM) were associated with prostate cancer risk. Methods Fifty-five thousand nine hundred thirty-se...

Full description

Bibliographic Details
Main Authors: Kerri Beckmann, Beth Russell, Debra Josephs, Hans Garmo, Christel Haggstrom, Lars Holmberg, Pär Stattin, Mieke Van Hemelrijck, Jan Adolfsson
Format: Article
Language:English
Published: BMC 2019-06-01
Series:BMC Cancer
Subjects:
Prostate cancer
Chronic inflammatory disease
Autoimmune disease
Anti-inflammatory medication
Online Access:http://link.springer.com/article/10.1186/s12885-019-5846-3

Internet

http://link.springer.com/article/10.1186/s12885-019-5846-3

Similar Items